SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 131 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $551,000 | +26.1% | 36,720 | +2.2% | 0.00% | – |
| Q1 2016 | $437,000 | -9.0% | 35,946 | +19.2% | 0.00% | -100.0% |
| Q4 2015 | $480,000 | +26.3% | 30,163 | +21.5% | 0.00% | 0.0% |
| Q3 2015 | $380,000 | -49.3% | 24,816 | -19.5% | 0.00% | 0.0% |
| Q2 2015 | $750,000 | +34.9% | 30,829 | +29.1% | 0.00% | 0.0% |
| Q1 2015 | $556,000 | +54.0% | 23,879 | +66.2% | 0.00% | – |
| Q4 2014 | $361,000 | -7.4% | 14,365 | +14.4% | 0.00% | – |
| Q3 2014 | $390,000 | +18.9% | 12,556 | -1.3% | 0.00% | – |
| Q2 2014 | $328,000 | +15.1% | 12,718 | +4.5% | 0.00% | – |
| Q1 2014 | $285,000 | +5.2% | 12,173 | +13.9% | 0.00% | – |
| Q4 2013 | $271,000 | +39.7% | 10,683 | +12.5% | 0.00% | – |
| Q3 2013 | $194,000 | – | 9,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |